ZBH Stock Zimmer Biomet Holdings, Inc.
US · NYSELast in our picks 2026-10-05 — not in the current list; analysis below is from that screen
Orthopedics recovery and valuation gap offer attractive re-rating potential.
Future value: $107.57 (+21.84%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Recovery catalyst in orthopedic demand and margin leverage.
- ▾Below 50-day MA (-8.11%)
- ▸~22% upside to price target
Is ZBH a buy right now?
Trend: ZBH is trading above the 50-day average (+2.46%), RSI 66 — neutral momentum, with a 3-month return of +1.77%.
Valuation & quality: Zimmer Biomet Holdings, Inc. trades on a trailing P/E of 23.7, forward P/E 10.7, PEG 0.62, price-to-book 1.47; fundamentals show net margin 9.5%, return on equity 6.4%, revenue growth 4.8% year on year.
Analyst consensus: 21 analysts have a mean 12-month price target of $106.90 (+9.7% vs the last close; range $93.00 – $130.00), consensus rating “buy”.
Income: trailing dividend yield 0.99%.
Our screen: BUY (score 2) — Orthopedics recovery and valuation gap offer attractive re-rating potential.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -8.10% | -8.80% | -0.10% | +4.60% | +9.10% | +6.50% | -11.20% | +9.70% |
Fundamentals
Analyst price target
Technical signals
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Sector: Healthcare · Industry: Medical Devices · United States · 17,000 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.